ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -0.96%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.605
      -0.21%
      Bitcoin
      65,791.29
      -0.20%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aurinia Pharmaceuticals Inc (AUPH)

      7. Aurinia Pharmaceuticals Inc (AUPH) Financials

      Aurinia Pharmaceuticals Inc

      Aurinia Pharmaceuticals Inc (AUPH)

      NASDAQ
      5.45
      0.02
      (0.37%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      5.40
      -0.05
      (-0.92%)
      After Hours: 7:57PM
      Delayed by 15 minutes

      Aurinia Pharmaceuticals Inc Financial Summary

      The current AUPH market cap is 772.3M. The company's latest EPS is USD -0.5455 and P/E is -9.99.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 34.41M44.83M54.52M45.1M54.43M
      Operating Income -29.58M-16.46M-13.62M-28.98M-13.25M
      Net Income -26.21M-11.49M-13.45M-26.88M-10.75M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 372k50.12M45.61M135.55M175.51M
      Operating Income -85.3M-104.29M-180.74M-111.47M-91.69M
      Net Income -123.85M-102.68M-180.97M-108.18M-78.02M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 451.76M548.9M555.01M548.06M516.63M
      Total Liabilities 61.35M156.61M163.14M170.11M157.16M
      Total Equity 390.41M392.29M391.88M377.95M359.48M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 326.68M463.66M543.37M470.86M548.06M
      Total Liabilities 53.17M55.91M64.28M65.43M170.11M
      Total Equity 273.52M407.75M479.09M405.44M377.95M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -31.67M-34.5M-47.77M-33.46M-18.6M
      Investing 24.86M19.25M-449k-6.71M49.23M
      Financing 1.64M2.78M447k-5.13M-15.05M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -63.46M-69.86M-157.69M-79.53M-33.46M
      Investing 7.78M-158.19M-103.87M-60.63M-6.71M
      Financing 243.73M194.38M221.11M2.43M-5.13M

      Stats and Ratios

      Market Cap 772.3M
      Price to Earnings Ratio -9.99
      Price to Sales Ratio 4.44
      Price to Cash Ratio 15.95
      Price to Book Ratio 2.06
      Dividend Yield -

      Share Statistics

      Shares Outstanding 143.02M
      Average Volume (1 week) 1.48M
      Average Volume (1 Month) 1.24M
      52 Week Change -50.73%
      52 Week High 12.43
      52 Week Low 4.71
      Spread (Intraday) 0.15 (2.7%)

      Company Info

      Company Name Aurinia Pharmaceuticals Inc
      Address 1203-4464 markham street
      victoria, british columbia V8Z 7X8
      Website https://www.auriniapharma.com
      Industry pharmaceutical preparations (2834)